Literature DB >> 7663810

Exhaustive treadmill exercise does not reduce twitch transdiaphragmatic pressure in patients with COPD.

M I Polkey1, D Kyroussis, S E Keilty, C H Hamnegard, G H Mills, M Green, J Moxham.   

Abstract

Reduced diaphragm contractility has been described in normal subjects after whole body endurance exercise, and it indicates low frequency fatigue (LFF); it is unknown whether LFF is of clinical importance. We therefore studied the effect of treadmill exercise to exhaustion on diaphragm contractility in six patients with severe chronic obstructive pulmonary disease (COPD) (mean FEV1, 0.71, 27% predicted). The subjects first performed a short (control), treadmill walk and then, after resting, a second walk to a state of severe dyspnea. Cervical magnetic stimulation of the phrenic nerve roots was performed at the start of the study and 20 and 30 min after each walk. The twitch transdiaphragmatic pressure (Tw Pdi) was reproducible (mean coefficient of variation, 5.3%; range, 2 to 12.5%). Mean Twi Pdis were 18.4 cm H2O at baseline and 19.6 cm H2O and 19.2 cm H2O 20 and 30 min after the control walk. At the same times after the exhaustive walk, mean Tw Pdis were 19.6 and 20.4 cm H20. Tw Pdi was not reduced by exhaustive treadmill walking (p > 0.9), and a power calculation showed that the study had a 95% chance of detecting a 10% fall at the 5% significance level. We conclude that Tw Pdi is not reduced when patients with severe COPD walk to a state of extreme breathlessness and that therefore low frequency fatigue of the diaphragm does not occur.

Entities:  

Mesh:

Year:  1995        PMID: 7663810     DOI: 10.1164/ajrccm.152.3.7663810

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  16 in total

Review 1.  Respiratory and lower limb muscle function in interstitial lung disease.

Authors:  Marios Panagiotou; Vlasis Polychronopoulos; Charlie Strange
Journal:  Chron Respir Dis       Date:  2016-01-14       Impact factor: 2.444

Review 2.  Assessment of respiratory muscle function and strength.

Authors:  N Syabbalo
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401

3.  Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.

Authors:  Markus Amann; Mark S Regan; Majd Kobitary; Marlowe W Eldridge; Urs Boutellier; David F Pegelow; Jerome A Dempsey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-05       Impact factor: 3.619

Review 4.  COPD exacerbations . 3: Pathophysiology.

Authors:  D E O'Donnell; C M Parker
Journal:  Thorax       Date:  2006-04       Impact factor: 9.139

5.  Locomotor and diaphragm muscle fatigue in endurance athletes performing time-trials of different durations.

Authors:  Thomas U Wüthrich; Elisabeth C Eberle; Christina M Spengler
Journal:  Eur J Appl Physiol       Date:  2014-04-29       Impact factor: 3.078

6.  Abdominal muscle fatigue following exercise in chronic obstructive pulmonary disease.

Authors:  Nicholas S Hopkinson; Mark J Dayer; John Moxham; Michael I Polkey
Journal:  Respir Res       Date:  2010-02-04

Review 7.  Respiratory muscle fiber remodeling in chronic hyperinflation: dysfunction or adaptation?

Authors:  Thomas L Clanton; Sanford Levine
Journal:  J Appl Physiol (1985)       Date:  2009-04-09

Review 8.  Assessing respiratory drive and central motor pathway in humans: clinical implications.

Authors:  B Binazzi; B Lanini; G Scano
Journal:  Lung       Date:  2004       Impact factor: 2.584

9.  Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary disease.

Authors:  Alison K Stubbings; Alastair J Moore; Michael Dusmet; Peter Goldstraw; Timothy G West; Michael I Polkey; Michael A Ferenczi
Journal:  J Physiol       Date:  2008-03-27       Impact factor: 5.182

Review 10.  New modalities of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.

Authors:  Martijn A Spruit; Emiel F M Wouters
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.